Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review.
Authors:
Posted in Papers / Human Studies|Original Research|Reviews / November 1-15, 2022
Headache. 2022 Nov 2. Online ahead of print.
PMID: 36321947 | DOI: 10.1111/head.14404
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.